Ohio State University B-Vaxx Report, page-15

Shemara I'm not sure how long you have invested in biotech stocks but I'm guessing not very long. You disclose that you don't hold IMU shares which makes me think you're clearly trying to talk down what are pretty amazing preliminary results in the hope of picking some up at a lower price. Pathetic attempt mate.

You clearly have zero understanding of what constitutes a successful trial. In one of my many conversations with Leslie, she once told me that if a vaccine/drug extended the life of a terminally ill cancer patient by even 3 months then that drug would be classed as a wonder drug. Sales of it would likely be in the hundreds of millions of dollars globally. So perhaps think twice before you shoot off your mouth about subjects you know nothing about.